非类固醇抗炎药物使用与良性前列腺增生风险之间的因果关系:一个单变和多变的门德尔随机化研究
Zi-He Peng1,2, Ming-Rui Li1,2, Min-Xin He1,2
1Department of Urology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, Shaanxi, China.
BMC medical genomics
|April 1, 2025
概括
基因预测使用非类固醇抗炎药物 (NSAIDs) 可能会增加良性前列腺增生 (BPH) 的风险. 需要进一步的研究,以了解NSAID和BPH风险之间的潜在机制.
科学领域:
- 药物基因组学 药物基因组学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 流行病学 流行病学
背景情况:
- 对非类固醇抗炎药物 (NSAIDs) 和良性前列腺激增症 (BPH) 风险的观察性研究产生了不一致的结果.
- 建立NSAID使用和BPH之间的因果关系对于了解疾病病因至关重要.
研究的目的:
- 调查基因预测的NSAID使用与发展BPH的风险之间的潜在因果关系.
- 利用门德尔的随机化来克服以前的观察性研究的局限性.
主要方法:
- 使用单变量和多变量门德尔随机化 (MR) 分析.
- 采用来自英国生物银行和来自FinnGen联盟的BPH总结数据 (30,066例,119,297例控制) 的工具变量.
- 进行敏感性分析以评估异质性和性.
主要成果:
- 无变MR表明,基因预测的NSAID使用与BPH风险增加有关 (OR: 1.164,p=0.008).
- 经过对炎症进行调整后,多变量MR证实了这一关联 (OR: 1.165,p=0.004).
- 在MR分析中没有检测到显著的异质性或性.
结论:
- 门德尔随机化估计表明,基因预测NSAID使用和BPH风险增加之间存在潜在的因果关系.
- 这些发现凸显了进一步研究这种关联背后的生物机制的必要性.
相关概念视频
Genome-wide Association Studies-GWAS
12.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.2K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
316
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
316
Peptic Ulcer Disease I: Introduction
106
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
106
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
323
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
323
Internal Receptors
68.9K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
68.9K


